Nilsine Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $604K | Sell |
4,994
-24
| -0.5% | -$2.9K | 0.06% | 243 |
|
|
2025
Q1 | $559K | Sell |
5,018
-346
| -6% | -$38.6K | 0.06% | 226 |
|
|
2024
Q4 | $522K | Sell |
5,364
-20
| -0.4% | -$1.95K | 0.06% | 250 |
|
|
2024
Q3 | $619K | Sell |
5,384
-405
| -7% | -$46.6K | 0.08% | 212 |
|
|
2024
Q2 | $616K | Buy |
5,789
+110
| +2% | +$11.7K | 0.08% | 214 |
|
|
2024
Q1 | $549K | Sell |
5,679
-226
| -4% | -$21.9K | 0.08% | 223 |
|
|
2023
Q4 | $596K | Sell |
5,905
-3,572
| -38% | -$361K | 0.09% | 210 |
|
|
2023
Q3 | $965K | Buy |
9,477
+43
| +0.5% | +$4.38K | 0.15% | 165 |
|
|
2023
Q2 | $952K | Buy |
9,434
+58
| +0.6% | +$5.85K | 0.14% | 172 |
|
|
2023
Q1 | $863K | Buy |
+9,376
| New | +$863K | 0.14% | 177 |
|